A phase II, single arm study assessing the efficacy of pembrolizumab (Pembro) plus radiotherapy (RT) in metastatic triple negative breast cancer (mTNBC) - McArthur, H L; Barker, C A; Gucalp, A (J Clin Oncol, 2018)
(Suppl.)